Immunologic factors in the pathogenesis of osteonecrosis

Orthopedic Clinics of North America

Volumn 35, Issue 3, 2004, Pages 259-263

  Tektonidou, Maria G ^a   Moutsopoulos, Haralampos M ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; CORTICOSTEROID; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOLOGIC FACTOR; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; AVASCULAR NECROSIS; BONE NECROSIS; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DEEP VEIN THROMBOSIS; FAT EMBOLISM; HUMAN; HYPERLIPIDEMIA; LEUKOPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAYNAUD PHENOMENON; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SMALL VESSEL VASCULITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TOTAL HIP PROSTHESIS;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; FEMALE; FEMUR HEAD NECROSIS; HUMANS; IMMUNOLOGIC FACTORS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MALE; OSTEONECROSIS; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 3242735502     PISSN: 00305898     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ocl.2004.02.003     Document Type: Review

References (50)

1. Mankin H.J. Nontraumatic necrosis of bone (osteonecrosis). N Engl J Med. 326(22):1992;1473-1479
2. Zabinski S.J., Sculco T.P., Dicarlo E.F., Rivelis M. Osteonecrosis in the rheumatoid femoral head. J Rheumatol. 25(9):1998;1674-1680
3. Van Vugt R.M., Sijbrandij E.S., Bijlsma J.W. Magnetic resonance imaging of the femoral head to detect avascular necrosis in active rheumatoid arthritis treated with methylprednisolone pulse therapy. Scand J Rheumatol. 25(2):1996;74-76
4. Martinez-Cordero E. Avascular necrosis of bone in systemic sclerosis. Clin Rheumatol. 11(4):1992;443-444
5. Wilde A.H., Mankin H.J., Rodman G.P. Avascular necrosis of the femoral head in scleroderma. Arthritis Rheum. 13(4):1970;445-447
6. Dubois E.L., Cozen L. Avascular necrosis in SLE. JAMA. 174:1960;966-971
7. Goldie I., Tibblin G., Scheller S. Systemic lupus erythematosus and aseptic bone necrosis. Acta Med Scand. 182(1):1967;55-63
8. Hurley R.M., Steinberg R.H., Patriquin H., Drummond K.N. Avascular necrosis of the femoral head in childhood systemic lupus erythematosus. Can Med Assoc J. 111(8):1974;781-784
9. Abeles M., Urman J.D., Rothfield N.F. Aseptic necrosis of bone in systemic lupus erythematosus. Relation to corticosteroid therapy. Arch Intern Med. 138(5):1978;750-754
10. Zizic T.M., Marcoux C., Hungerford D.S., Danserau J.V., Stevens M.B. Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Am J Med. 79(5):1985;596-604
11. Kalla A.A., Learmonth I.D., Klemp P. Early treatment of avascular necrosis in systemic lupus erythematosus. Ann Rheum Dis. 45(8):1986;649-652
12. Nilsen K.H. Systemic lupus erythematosus and avascular bone necrosis. N Z Med J. 85(589):1977;472-475
13. Klipper A.R., Stevens M.B., Zizic T.M., Hungerford D.S. Ischemic necrosis of bone in systemic lupus erythematosus. Medicine (Baltimore). 55(3):1976;251-257
14. Fisher D.E., Bickel W.H., Holley K.E. Histologic demonstration of fat emboli in aseptic necrosis associated with hypercortisonism. Mayo Clin Proc. 44:1969;252-259
15. Boettcher W.G., Bonfiglio M., Hamilton H.H., Sheets R.F., Smith K. Nontraumatic necrosis of the femoral head. Relation of altered hemostasis to etiology. J Bone Joint Surg [Am]. 52(2):1970;312-321
16. Hungerford D.S. Pathogenetic considerations in ischaemic necrosis of bone. Can J Surg. 24(6):1981;583-587
17. Smith F.E., Sweet D.E., Brunner C.M., Davis J.S. Avascular necrosis in SLE. An apparent predilection for young patients. Ann Rheum Dis. 35(3):1976;227-232
18. Rascu A., Manger K., Kraetsch H.G., Kalden J.R., Manger B. Osteonecrosis in systemic lupus erythematosus, steroid induced or a lupus-dependent manifestation? Lupus. 5(4):1996;323-327
19. Asherson R.A., Liote F., Page B., Meyer O., Buchanan N., Khamashta M.A., et al. Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol. 20(2):1993;284-288
20. Nagasawa K., Ishi Y., Mayumi T., Tada Y., Ueda A., Yamauchi Y., et al. Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities. Ann Rheum Dis. 48(8):1989;672-676
21. Mont M.A., Glueck C.J., Pacheco I.H., Wang P., Hungerford D.S., Petri M. Risk factors for osteonecrosis in systemic lupus erythematosus. J Rheumatol. 24(4):1997;654-662
22. Roubey R.A. Autoantibodies to phospholipid-binding plasma proteins. A new view of lupus anticoagulants and other "antiphospholipid" autoantibodies. Blood. 84(9):1994;2854-2867
23. McNeil H.P., Simpson R.J., Chesterman C.N., Krilis S.A. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A. 87(11):1990;4120-4124
24. Hughes G.R. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J (Clin Res Ed). 287(6399):1983;1088-1089
25. Gruppo R., Glueck C.J., McMahon R.E. The pathophysiology of alveolar osteonecrosis of the jaw: anticardiolipin antibodies, thrombophilia and hypofibrinolysis. J Lab Clin Med. 127(5):1996;481-488
26. Van Veldhuizen P.J., Neff J., Murphey M.D., Bodensteiner D., Skikne B.S. Decreased fibrinolytic potential in patients with idiopathic avascular necrosis and transient osteoporosis of the hip. Am J Hematol. 44(4):1993;243-248
27. Glueck C.J., Crawford A., Roy D., Freiberg R., Glueck H., Stroop D. Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease. J Bone Joint Surg [Am]. 78(1):1996;3-13
28. Glueck C.J., Freiberg R., Tracy T., Stroop D., Wang P. Thrombophilia and hypofibrinolysis. Pathophysiologies of osteonecrosis. Clin Orthop. 334:1997;43-56
29. Glueck C.J., McMahon R.E., Bouquot J.E., Stroop D., Tracy T., Freiberg R., et al. The pathophysiology of idiopathic osteonecrosis of the jaws: thrombophilia and hypofibrinolysis [abstract]. J Invest Med. 43(Suppl2):1995;234A
30. Alijotas J., Argemi M., Barquinero J. Kienbock's disease and antiphospholipid antibodies. Clin Exp Rheumatol. 8(3):1990;297-298
31. Korompilias A.V., Gilkeson G.S., Ortel T.L., Seaber A.V., Urbaniak J.R. Anticardiolipin antibodies and osteonecrosis of the femoral head. Clin Orthop. 345:1997;174-180
32. Miller K.D., Masur H., Jones E.C., Joe G.O., Rick M.E., Kelly G.G., et al. High prevalence of osteonecrosis of the femoral head in HIV-infected adults. Ann Intern Med. 137(1):2002;17-25
33. Alarcon-Segovia D., Deleze M., Oria C.V., Sanchez-Guerrero J., Gomez-Pacheco L., Cabiedes J., et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine. 68(6):1989;353-365
34. Asherson R.A., Jungers P., Liote F. Ischaemic necrosis of bone associated with the "lupus anticoagulant" and antibodies to cardiolipin [abstract]. In: Proceedings of the XIVth International Congress of Rheumatology, Sydney, Australia, May 19-25, 1985. p. 373
35. Petri M. Muscosceletal complications of systemic lupus erythematosus in the Hopkins Lupus Cohort: an update. Arthritis Care Res. 8(3):1995;137-145
36. Pistiner M., Wallace D.J., Nessim S., Metzger A., Klinenberg J.R. Lupus erythematosus in the 1980s: a survey of 570 patients. Sem Arthritis Rheum. 21(1):1991;55-64
37. Migliaresi S., Picillo U., Ambrosone L., Di Palma G., Mallozzi M., Tesone E.R., et al. Avascular osteonecrosis in patients with SLE: relation to corticosteroid therapy and anticardiolipin antibodies. Lupus. 3(1):1994;37-41
38. Houssiau F.A., N' Zeusseu Toukap A., Depresseux G., Maldague B.E., Malghem J., Devegelaer J.P., et al. Magnetic resonance imaging-detected avascular osteonecrosis in systemic lupus erythematosus: lack of correlation with antiphospholipid antibodies. Br J Rheumatol. 37(4):1998;448-453
39. Fisher D.E., Bickel W.H. Corticosteroid induced avascular necrosis. A clinical study of seventy-seven patients. J Bone Joint Surg [Am]. 53(5):1971;859-873
40. Felson D.T., Anderson J.J. A cross-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone. Lancet. 1(8538):1987;902-906
41. Coleman B.G., Kressel H.Y., Dalinka M.K., Schiebler M.L., Burk D.L., Cohen E.K. Radiographically negative avascular necrosis: detection with MR imaging. Radiology. 168(2):1988;525-528
42. Vande Berg B.C., Malghem J.J., Lecouvet F.E., Jamart J., Maldague B.E. Idiopathic bone marrow edema lesions of the femoral head: predictive value of MR imaging findings. Radiology. 212(2):1999;527-535
43. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.C., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 42(7):1999;1309-1311
44. Asherson R.A., Khamashta M.A., Ordi-Ros J., et al. 'Primary' antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore). 68(6):1989;366-374
45. Tektonidou M.G., Ioannidis J.P.A., Boki K.A., Vlachoyiannopoulos P.G., Moutsopoulos H.M. Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome. QJM. 93:2000;523-530
46. Vela P., Battle E., Salas E., Marco O. Primary antiphospholipid syndrome and osteonecrosis. Clin Exp Rheumatol. 9(5):1991;545-546
47. Seleznick M.J., Silveira L.H., Espinosa L.R. Avascular necrosis associated with anticardiolipin antibodies. J Rheumatol. 18(9):1991;1416-1417
48. Egan R.M., Munn R.K. Catastrophic antiphospholipid antibody syndrome presenting with multiple thromboses and sites of avascular necrosis. J Rheumatol. 21(12):1994;2376-2379
49. Tektonidou M.G., Malagari K., Vlachoyiannopoulos P.G., Kelekis A.D., Moutsopoulos H.M. Asymptomatic avascular necrosis in patients with primary antiphospholipid syndrome. A prospective study by magnetic resonance imaging. Arthritis Rheum. 48:2003;732-736
50. Vlachoyiannopoulos P.G., Petrovas C., Tektonidou M., Krilis S., Moutsopoulos H.M. Antibodies to b2-Glycoprotein I: urea resistance, binding specificity and association with thrombosis. J Clin Immunol. 18:1998;380-391